Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 304 followers
Latest posts
Last updated about 16 hours ago
Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Date of authorisation: 23/03/2015, Revision: 26, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Sivextro, tedizolid phosphate, Date of...
Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation: 22/01/2007, Revision: 49, Status: Authorised
about 16 hours ago
Human medicines European public assessment report (EPAR): Lucentis, ranibizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Bexsero, meningococcal group B Vaccine (rDNA, component, adsorbed), Date of authorisation: 13/01/2013, Revision: 37, Status: Authorised
about 17 hours ago
Human medicines European public assessment report (EPAR): Bexsero, meningococcal group B Vaccine...
Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation: 20/01/2025, Revision: 5, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Kavigale, sipavibart, Date of authorisation...
Human medicines European public assessment report (EPAR): Rezolsta, darunavir,cobicistat, Date of authorisation: 19/11/2014, Revision: 20, Status: Authorised
about 18 hours ago
Human medicines European public assessment report (EPAR): Rezolsta, darunavir,cobicistat, Date of authorisation...
Human medicines European public assessment report (EPAR): Olumiant, baricitinib, Date of authorisation: 13/02/2017, Revision: 27, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Olumiant, baricitinib, Date of authorisation...
Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 30, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent...
Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 5, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Arava, leflunomide, Date of authorisation: 02/09/1999, Revision: 46, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Arava, leflunomide, Date of authorisation...
Human medicines European public assessment report (EPAR): Zutectra, human hepatitis B immunoglobulin, Date of authorisation: 30/11/2009, Revision: 20, Status: Authorised
15 days ago
Human medicines European public assessment report (EPAR): Zutectra, human hepatitis B immunoglobulin...
Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil, Date of authorisation: 16/12/2016, Revision: 19, Status: Authorised
6 days ago
Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil...
Human medicines European public assessment report (EPAR): Nordimet, methotrexate, Date of authorisation: 18/08/2016, Revision: 26, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): Nordimet, methotrexate, Date of authorisation...